Prospective evaluation of bone strength, physical activity, falls, subsequent fractures and mortality in patients presenting with a recent clinical fracture.

Prospective evaluation of bone strength, physical activity, falls, subsequent fractures and mortality in patients presenting with a recent clinical fracture. - Bone strength and physical activity in patients with a recent fracture

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41637

Enrollment

500

Registered

2013-12-17

Start date

2014-10-10

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

loss of bone mass

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 50 years and older with a recent fracture that is being evaluated at the FLS at VieCuri MC. 2. Patients who understand the conditions of the study and are willing and able to comply with the scheduled study procedures 3. Patients who signed the Ethics Committee approved specific Informed Consent Form prior to inclusion.

Exclusion criteria

Exclusion criteria: 1. Patients with malignancy metastatic to the bone. 2. Patients with osteomyelitis. 3. Patients with fractures due to failure of a prosthesis. 4. Patients, who as judged by the Principal Investigator, are mentally incompetent. Patients who are compos mentis and understand the patient information, will not be considered mentally incompetent.

Design outcomes

Primary

Measure	Time frame
Bone structure parameters, bone strength, physical activity, falls, subsequent fractures and mortality.	—

Secondary

Measure	Time frame
In addition, parameters assessed during regular care will be investigated such as clinical risk factors for fractures and osteoporosis, dietary calcium intake, fall risk assessment, muscle strength and function, gait quality, bone mineral density and laboratory analysis.	—

Countries

Netherlands

Outcome results